SQ Innovation is a privately-held Swiss biopharmaceutical company located in Zug, Switzerland, and Burlington, MA,. The company was established to develop and commercialize innovative cost-effective therapies for subcutaneous delivery of pharmaceutical products where and when needed. Its first product was designed specifically for the treatment of fluid overload due to worsening heart failure. The product is currently under review by the US FDA. The innovative combination product is based on a novel high-concentration formulation and uses a cost-effective two-component device design. The device was designed with the patient, provider, payor and environment in mind. The Infusor uses a reusable motorized component and a disposable component. The company's products are subject to regulatory review and approval.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 20 Mall Rd,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://sqinnovation.com
- HQ
- Burlington, Massachusetts
Sq Innovation Questions
Sq Innovation's website is http://sqinnovation.com
Sq Innovation's LinkedIn profile is https://www.linkedin.com/company/sq-innovation-inc
Sq Innovation has
20 employees.
View email and phone details for 20
employees at Sq Innovation.
Sq Innovation's industry is
Pharmaceutical Manufacturing
Sq Innovation's top competitors are
Alcresta Therapeutics,
Vericel® Corporation,
Agamatrix,
Scpharmaceuticals,
Eversana,
Infobionic.ai,
Intuvie,
Precision Neuroscience,
Activ Surgical,
Alnylam Pharmaceuticals.
Sq Innovation's categories are Pharmaceutical Manufacturing
Sq Innovation's founding year is 2019
